{"id":"W2039457659","doi":"10.1158/1535-7163.targ-11-a221","title":"Abstract A221: A phase II study of SB939 in patients with recurrent or metastatic castration resistant prostate cancer (CRPC).","year":2011,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital; Ontario Institute for Cancer Research; BC Cancer Agency","funders":"","keywords":"Medicine; Prostate cancer; Internal medicine; Clinical endpoint; Oncology; Cancer; Adverse effect; Androgen deprivation therapy; Lymph node; Prostate; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001279023,0.002089989,0.002074621,0.0004852893,0.0005081657,0.0008066672,0.0009629035,0.00109257,0.004561004],"category_scores_gemma":[0.0005637936,0.0006261028,0.00120649,0.0005085939,0.000768085,0.0005273127,0.0003330942,0.002480431,0.001554722],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007890332,"about_ca_system_score_gemma":0.00159535,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002319107,"about_ca_topic_score_gemma":0.004888492,"domain_scores_codex":[0.9996186,0.0001992751,0.00001923704,0.00006120751,0.00003717039,0.00006450644],"domain_scores_gemma":[0.9994527,0.00006096272,0.00008509011,0.00003854085,0.00003596571,0.0003267635],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5545056,0.1516085,0.01293111,0.001601392,0.00261012,0.001023279,0.000505487,0.003396608,0.1304298,0.0003233656,0.009266002,0.1317987],"study_design_scores_gemma":[0.3879554,0.5876575,0.01642646,0.00003637805,0.0005616738,0.000491565,0.00006825192,0.0009065733,0.003422412,0.00008677735,0.002356291,0.00003071155],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908103,0.002341571,0.0005496205,0.0004503268,0.0001137346,0.002516172,0.001464967,0.0001268315,0.00162659],"genre_scores_gemma":[0.9850154,0.002385879,0.001483066,0.001111156,0.0002378776,0.002420213,0.003738594,0.00005434528,0.003553447],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004561004,"threshold_uncertainty_score":0.01525807,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08893729981605718,"score_gpt":0.3766998605302653,"score_spread":0.2877625607142081,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}